PLSE

PULSE BIOSCIENCES, INC. PLSE

NasdaqMid CapHealthcare

13F Pro quality score

Rank #2,823 of 2,925

Why it scores 15Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$434.0K

Quarter to Jun 30

Net income

$-24.66M

Quarter to Jun 30

Free cash flow

$-18.80M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$296.39M total
BlackRock, Inc.
$40.67M+9.5%
BANK OF AMERICA CORP /DE/
$40.11M+67.0%
VANGUARD CAPITAL MANAGEMENT LLC
$21.87M-3.3%
Portolan Capital Management, LLC
$20.89M+2.7%
PRICE T ROWE ASSOCIATES INC /MD/
$20.76M+4938.3%
BALYASNY ASSET MANAGEMENT L.P.
$19.91M+170.8%
CITADEL ADVISORS LLC
$17.37M+340.7%
GEODE CAPITAL MANAGEMENT, LLC
$14.87M+9.0%
STATE STREET CORP
$14.69M+15.9%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$12.83M0.0%
UBS Group AG
$7.64M+711.9%
GRIFFIN ASSET MANAGEMENT, INC.
$6.30M+0.9%
VANGUARD PORTFOLIO MANAGEMENT LLC
$4.98M+8.7%
NORTHERN TRUST CORP
$4.81M-7.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$4.21M+2.9%
VANGUARD FIDUCIARY TRUST CO
$3.64M+0.5%
Point72 Asset Management, L.P.
$2.95MNew
NORGES BANK
$2.93M--
Nuveen, LLC
$2.82M+123.8%
Panoramic Capital, LLC
$2.72M+68.9%
D. E. Shaw & Co., Inc.
$2.27M+496.1%
Westside Investment Management, Inc.
$2.16M+10.3%
WELLINGTON MANAGEMENT GROUP LLP
$2.07M-8.0%
SECTORAL ASSET MANAGEMENT INC
$1.88MNew
Bank of New York Mellon Corp
$1.20M+12.1%
See all 106 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PLSE

Earnings Per Share

13fpro.ai/company/PLSE

Loading ratio trend…

PLSE key financials by period

Reported revenue, net income and operating margin by fiscal year, from PULSE BIOSCIENCES, INC.'s annual filings on SEC EDGAR.

PULSE BIOSCIENCES, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$350.0K$-72.8M—
FY 2022$700.0K$-58.5M—
FY 2021$1.4M$-63.7M—
FY 2019$983.0K$-47.0M—
FY 2018$446.0K$-37.5M—
FY 2017$247.0K$-25.6M—
Source: PLSE filings on SEC EDGAR →

PLSE insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About PULSE BIOSCIENCES, INC. (PLSE): stock profile, AI score and financials

PULSE BIOSCIENCES, INC. (PLSE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PLSE at 14.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,823 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), PULSE BIOSCIENCES, INC. reports quarterly revenue of $434.0K, net income of $-24.7M, free cash flow of $-18.8M. Top institutional holders of PLSE by reported 13-F value include BlackRock, BANK OF AMERICA, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. PLSE trades on the Nasdaq exchange and files with the SEC under CIK 1625101. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PLSE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PULSE BIOSCIENCES, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1625101 →